Hamilton James C Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$8.74M

Insider Activity of Hamilton James C

According to the SEC Form 4 filings, Hamilton James C, being in a position of

  1. Chief Medical Officer at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 60164 shares for $3.93M,
    over all time since 2021-01-05, has bought 0 shares, and sold 306792 shares for $14.39M.

Biography of Hamilton James C

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,926,5613100

Comparison of Insiders on Amount of Buys and Sells

2026-04-23SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
10,000
0.0072%
$75.00$750,000+2.79%
2026-03-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
10,000
0.0072%
$64.19$641,900+16.17%
2026-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
40,164
0.0287%
$63.11$2.53M+10.63%
2025-10-01SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
20,000
0.0147%
$35.00$700,000+94.4%
2025-09-12SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
15,000
0.011%
$30.00$450,000+126.87%
2025-09-02SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
15,000
0.0106%
$25.00$375,000+158.26%
2025-08-15SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
9,389
0.0066%
$20.00$187,780+216.43%
2025-08-13SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Medical Officer
611
0.0004%
$20.00$12,220+223.46%
2025-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Discovery/Trans Medicine
32,729
0.0265%
$19.82$648,824-2.23%
2024-04-01SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Discovery/Trans Medicine
6,000
0.0048%
$28.03$168,180-22.63%
2024-01-12SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Discovery/Trans Medicine
7,940
0.0075%
$36.89$292,904-32.72%
2024-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
32,143
0.0295%
$35.18$1.13M-30.63%
2024-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
6,300
0.0059%
$32.19$202,781-22.74%
2023-06-30SaleArrowhead Pharmaceuticals, Inc.
ARWR
3,000
0.0028%
$35.53$106,590-21.76%
2023-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
13,803
0.013%
$37.40$516,232-17.88%
2023-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
10,338
0.0097%
$38.38$396,738-20.9%
2022-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
6,250
0.0061%
$61.72$385,773-34.2%
2022-01-04SaleArrowhead Pharmaceuticals, Inc.
ARWR
19,375
0.0185%
$65.49$1.27M-39.08%
2021-01-14SaleArrowhead Pharmaceuticals, Inc.
ARWR
10,000
0.0094%
$81.29$812,942-17.84%
2021-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
19,375
0.0182%
$72.48$1.4M-7.92%
Total: 21
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.